Dr. Samir Mukundray Dalia, MD

Dr. Dalia practices at Mercy Hospital Joplin in Joplin, Missouri, part of Mercy.

Dr. Dalia's NPI, 1235331455, was assigned on June 1, 2007. Dr. Dalia graduated from Northeastern Ohio University College of Medicine in 2007. Dr. Dalia holds Missouri license 2014012975.

Dr. Dalia's primary practice is Mercy Hospital Joplin, at 100 Mercy Way, Joplin, MO 64804 in Jasper County. The practice phone is (417) 781-2727.

Dr. Dalia's primary practice is Mercy Hospital Joplin in Joplin, Missouri, part of Mercy. Dr. Dalia is also affiliated with Mercy Hospital Carthage. The medical group on file is Mercy Clinic Family Medicine - Hollister. Dmand AI also links Dr. Dalia to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dalia practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dalia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dalia is licensed in Missouri.

CMS data shows 4,318 Medicare services from Dr. Dalia across 11 procedure codes in 2024, for 536 Medicare patients. Medicare paid $170,295 for them.

CMS counts 536 Medicare patients who saw Dr. Dalia in 2024. The largest group is 65 to 74, with 240 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dalia's median patient age at 74, with 52% women.

In 2024, Dr. Dalia wrote 2,329 Medicare Part D claims for 365 patients. 83% of them were for generic drugs. CMS names the drug for 1,929 of them, across 54 drugs with 11 or more claims each, at $3,792,684 in total drug cost. In 2023, CMS named 2,033 claims across 59 drugs.

Dr. Dalia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 56 papers to Dr. Dalia, published from 2010 to 2025. 2014 was the busiest year, with 11. The most frequent topics are Lymphoma, Non-Hodgkin, Disease Progression and Hepatitis B. Dr. Dalia has published most often in Ann Transl Med. Dr. Dalia's most frequent co-authors are Lubomir Sokol, MD, Julio C. Chavez, MD and Javier A. Pinilla-Ibarz, MD.

Dmand AI links Dr. Dalia to 10 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. Exact Sciences Corporation sponsors the most, 2.

CMS Open Payments shows 115 general payments to Dr. Dalia from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 41% of the total. AstraZeneca Pharmaceuticals LP paid the most, $875.

Dr. Dalia graduated from Northeastern Ohio University College of Medicine in 2007.